share_log

Baird Downgrades Inari Medical to Neutral, Lowers Price Target to $80

Baird Downgrades Inari Medical to Neutral, Lowers Price Target to $80

贝尔德将Inari Medical评级下调至中立,并将目标价格下调至80美元。
Benzinga ·  01/07 18:18  · 评级/大行评级

Baird analyst David Rescott downgrades Inari Medical (NASDAQ:NARI) from Outperform to Neutral and lowers the price target from $81 to $80.

Baird 分析师 David Rescott 将 Inari Medical (纳斯达克:NARI) 的评级从跑赢大盘下调至中立,并将目标价从81美元下调至80美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发